Skip to main content
OpenTrials
Completed

NCT Number: NCT01508481

Vitamin D Inadequacy is Associated With Incidence of Type 2 Diabetes

Emerging evidence suggests that vitamin D [25-hydroxyvitamin D; 25(OH)D] may play a role in the etiology of type 2 diabetes. Vitamin D levels are lower in those with type 2 diabetes and impaired glucose tolerance (IGT) compared with those with normal glucose tolerance (NGT). In addition, a few prospective studies have shown a significant inverse association of baseline serum 25(OH)D with incident diabetes. To date, however, the exact mechanisms through which vitamin D affects diabetes risk are not yet fully known, particularly whether vitamin D plays a role in insulin resistance (IR) and/or b-cell dysfunction, the main pathophysiological disorders underlying type 2 diabetes. So, the investigators plan to examine the prospective associations of baseline vitamin D [25-hydroxyvitamin D; 25(OH)D] with insulin resistance (IR), b-cell function, and glucose homeostasis in subjects at risk for type 2 diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Bundang Hospital

Seongnam, 463-707, South Korea

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • one or more risk factors for diabetes, including:
  • obesity
  • hypertension
  • dislipidemia
  • a family history of diabetes

Exclusion criteria

  • previous diagnosed diabetes
  • vitamin D supplement.

Treatment and study plan

Primary outcomes

  1. Incidence of diabetes

    Time frame: 5 years

    Incidence of diabetes defined by American Diabetes Association criteria

Secondary outcomes

  1. Pancreatic beta cell function

    Time frame: 5 years

    Pancreatic beta cell function assessed by homeostasis model

  2. Insulin resistance

    Time frame: 5 years

    Insulin resistance assessed by homeostasis model

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Important dates

Study start
2007
Primary completion
2012
Study completion
2012
First posted
Jan 12, 2012
Registry last updated
Oct 10, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.